P. Schirmacher

Hepatology · 2008–2021

A researcher in the Science corpus: 7 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom P. Schirmacher trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Jordi Bruix1 , 2 (in Hepatology)

Papers from P. Schirmacher's perspective

Ordered by how strongly the researchers P. Schirmacher trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. (The Lancet Oncology)
  2. INCIDENCE OF HEPATOCELLULAR CARCINOMA AND ASSOCIATED RISK FACTORS IN HEPATITIS C-RELATED ADVANCED LIVER DISEASE (Gastroenterology)
  3. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival (Hepatology)
  4. The natural history of compensated cirrhosis due to hepatitis C virus: A 17‐year cohort study of 214 patients (Hepatology)
  5. Use of archived specimens in evaluation of prognostic and predictive biomarkers. (Journal of the National Cancer Institute)
  6. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma (Hepatology)
  7. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. (Journal of Hepatology)
  8. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. (Gastroenterology)
  9. Randomized controlled trial of screening for hepatocellular carcinoma (Journal of Cancer Research and Clinical Oncology)
  10. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. (Gastroenterology)

Their papers